Status:

UNKNOWN

Prone Position in infantS/Children With Acute Respiratory Distress Syndrome

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

Prone Position

Acute Respiratory Distress Syndrome

Eligibility:

All Genders

Up to 18 years

Phase:

NA

Brief Summary

In adult patients with acute respiratory distress syndrome (ARDS), the beneficial effects of prone position (PP) have been well investigated and explored; it reduces intrapulmonary shunt (Qs/Qt) and e...

Detailed Description

Each patient meeting inclusion criteria will be evaluated for the presence of the oxygenation criterion. After neuromuscular paralysis (or apnoeic ventilation as per PICU protocol), and endotracheal s...

Eligibility Criteria

Inclusion

  • PaO2/FiO2 \< 200 in the supine position, with a standard PEEP of 5 cmH2O;
  • PaCO2 \<45mmHg;
  • Absence of history of chronic respiratory disease or heart failure or congenital heart disease (Modified Ross heart failure classification for children \< II);
  • Not underweight infants/children defined as a low body mass index (BMI) for age;
  • Absence of any contraindication to PP (Appendix 1);
  • Written informed consent of both parents and the legal guardian.

Exclusion

  • Barotrauma;
  • Less than 4 weeks of age (new-born physiology);
  • Exacerbation of asthma;
  • Chest trauma;
  • Pulmonary oedema/haemorrhage;
  • Severe Neutropenia (\<500 WBC/mm3);
  • Haemodynamic instability (Systolic blood pressure \< 5th percentile or mean arterial pressure \< 5th percentile adjusted by age);
  • Lactic acidosis (lactate \>5 mmol/L) and/or clinically diagnosed shock;
  • Metabolic Acidosis (pH \<7.30 with normal- or hypo-carbia);
  • Chronic kidney failure requiring dialysis before PICU admission;
  • Upper gastrointestinal bleeding.
  • Refusal to sign written informed consent of both parents and the legal guardian.

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06020404

Start Date

September 1 2023

End Date

September 1 2025

Last Update

February 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Giorgio Conti

Rome, Italy, 00168